Press Release: Mergers: Commission approves acquisition of Belgian health company Omega Pharma by private equity fund manager Waterland and Belgian Alychlo

The European Commission has cleared under the EU Merger Regulation the proposed acquisition of Omega Pharma NV, a Belgian provider of Over-the-Counter (OTC) health care products, by the Belgian holding company Alychlo NV and a fund controlled by Waterland Private Equity Investment B.V.

The Commission concluded that the merged entity would continue to face effective competition in the markets for OTC pharmaceuticals and other health care products as well as in the respective downstream distribution markets.